Isaacs Joseph D, McMullen Todd P W, Sidhu Stan B, Sywak Mark S, Robinson Bruce G, Delbridge Leigh W
University of Sydney Endocrine Surgery Unit, Sydney, Australia.
ANZ J Surg. 2010 Nov;80(11):834-8. doi: 10.1111/j.1445-2197.2010.05334.x.
Recent published data has shown that metastatic involvement of the prelaryngeal or Delphian lymph node (DLN), the highest of the central (level VI) cervical lymph nodes, is highly predictive of advanced nodal disease in papillary thyroid cancer (PTC). The aims of this study were to determine the diagnostic accuracy of all the level VI cervical nodes in PTC and to determine which node group, if any, is the most accurate in predicting lateral node (N1b) disease.
This was a retrospective cohort study. Data were obtained from the University of Sydney Endocrine Surgical Unit Database and through a review of the histopathology records. The study cohort was composed of 177 consecutive patients with a final diagnosis of PTC who underwent total thyroidectomy and lymph node dissection, spanning the period from May 2001 to December 2006.
Of the 177 patients with PTC, 86 had the DLN removed, 51 had a pretracheal node removed and 76 had the paratracheal group removed. DLN, paratracheal and pretracheal node disease was present in 21%, 39% and 46%, respectively. Lateral node (N1b) disease was present in 35%. Paratracheal node involvement was mildly predictive of further disease with patients 1.7 times more likely to have lateral node involvement (sensitivity=55%, specificity=68%). Pretracheal node involvement was moderately predictive of further disease with patients three times more likely to have lateral node involvement (sensitivity=72%, specificity=74%). DLN involvement was highly predictive of further node involvement with patients nine times more likely to have lateral node disease (sensitivity=53%, specificity=94%) and 40 times more likely to have any nodal disease (sensitivity=41%, specificity=100%).
This is the first study to examine the diagnostic accuracy of all level VI lymph nodes in PTC. While, metastatic involvement of all central nodal groups is indicative of further disease, the DLN is the most accurate predictor.
最近发表的数据表明,喉前或德尔菲淋巴结(DLN)是中央(Ⅵ区)颈部淋巴结中位置最高的淋巴结,其转移累及对乳头状甲状腺癌(PTC)晚期淋巴结疾病具有高度预测性。本研究的目的是确定PTC中所有Ⅵ区颈部淋巴结的诊断准确性,并确定哪一组淋巴结(如果有的话)在预测侧方淋巴结(N1b)疾病方面最准确。
这是一项回顾性队列研究。数据来自悉尼大学内分泌外科数据库,并通过回顾组织病理学记录获得。研究队列由177例最终诊断为PTC且接受全甲状腺切除术和淋巴结清扫术的连续患者组成,时间跨度为2001年5月至2006年12月。
177例PTC患者中,86例切除了DLN,51例切除了气管前淋巴结,76例切除了气管旁淋巴结组。DLN、气管旁和气管前淋巴结疾病的发生率分别为21%、39%和46%。侧方淋巴结(N1b)疾病的发生率为35%。气管旁淋巴结受累对进一步疾病有轻度预测性,患者发生侧方淋巴结受累的可能性高1.7倍(敏感性=55%,特异性=68%)。气管前淋巴结受累对进一步疾病有中度预测性,患者发生侧方淋巴结受累的可能性高3倍(敏感性=72%,特异性=74%)。DLN受累对进一步淋巴结受累有高度预测性,患者发生侧方淋巴结疾病的可能性高9倍(敏感性=53%,特异性=94%),发生任何淋巴结疾病的可能性高40倍(敏感性=41%,特异性=100%)。
这是第一项研究PTC中所有Ⅵ区淋巴结诊断准确性的研究。虽然所有中央淋巴结组的转移累及都表明有进一步疾病,但DLN是最准确的预测指标。